PBS Biotech is advancing the future of cell therapy manufacturing through innovative, single-use bioreactor solutions designed specifically for shear-sensitive cell cultures. Our proprietary platform enables researchers and manufacturers to achieve superior cell growth, scalability, and process consistency—from early-stage discovery through commercial cGMP production. We provide a comprehensive portfolio of scalable, cost-effective bioreactor systems and expert process development services that help customers accelerate development timelines, reduce manufacturing risk, and bring life-changing therapies to patients faster. Trusted by leading biotech companies, academic institutions, and contract manufacturers worldwide, PBS Biotech is committed to simplifying cell therapy manufacturing while delivering exceptional performance at every stage of the journey. To learn more, contact our sales team at sales@pbsbiotech.com or visit PBS Biotech.
Looking for a particular PBS Biotech employee's phone or email?
The PBS Biotech annual revenue was $45.9 million in 2026.
Martin Simonetti is the CEO of PBS Biotech.
74 people are employed at PBS Biotech.
PBS Biotech is based in Camarillo, California.
The NAICS codes for PBS Biotech are [541, 5417, 54, 54171, 541713].
The SIC codes for PBS Biotech are [87, 873].